BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Rebecca Sanders, Deborah J. Mason, Carole A. Foy, Jim F. Huggett. Considerations for accurate gene expression measurement by reverse transcription quantitative PCR when analysing clinical samplesAnalytical and Bioanalytical Chemistry 2014; 406(26): 6471 doi: 10.1007/s00216-014-7857-x
2
Bing-jie Liu, Qi-ying Xu, Wei-dong Yu, Na Li, Tian Yao, Li-jun Zhao, Jian-liu Wang, Li-hui Wei, Xiao-ping Li. Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and RadioresistanceFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00070
3
Carole Mélin, Aurélie Perraud, Christophe Bounaix Morand du Puch, Elodie Loum, Stéphanie Giraud, Philippe Cardot, Marie-Odile Jauberteau, Christophe Lautrette, Serge Battu, Muriel Mathonnet. Sedimentation field flow fractionation monitoring of in vitro enrichment in cancer stem cells by specific serum-free culture mediumJournal of Chromatography B 2014; 963: 40 doi: 10.1016/j.jchromb.2014.05.039
4
Sònia Palomeras, Santiago Ruiz-Martínez, Teresa Puig. Targeting Breast Cancer Stem Cells to Overcome Treatment ResistanceMolecules 2018; 23(9): 2193 doi: 10.3390/molecules23092193
5
Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, Jose Prados. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-511
6
John Lynes, Victoria Sanchez, Gifty Dominah, Anthony Nwankwo, Edjah Nduom. Current Options and Future Directions in Immune Therapy for GlioblastomaFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00578
7
M Ozawa, Y Ichikawa, Y-W Zheng, T Oshima, H Miyata, K Nakazawa, H-B Guan, M Shiozawa, M Akaike, K Watanabe, M Ota, S Fujii, C Kunisaki, T Ishikawa, K Tanaka, H Akiyama, I Endo, H Taniguchi. Prognostic significance of CD44 variant 2 upregulation in colorectal cancerBritish Journal of Cancer 2014; 111(2): 365 doi: 10.1038/bjc.2014.253
8
Jie Chen, Lin Lin, Zhaopei Guo, Caina Xu, Huayu Tian, Kinam Park, Xuesi Chen. Synergistic treatment of cancer stem cells by combinations of antioncogenes and doxorubicinJournal of Drug Delivery Science and Technology 2015; 30: 417 doi: 10.1016/j.jddst.2015.06.004
9
Lan Yu, Lei Zhou, Shiwu Wu, Xiaomeng Gong, Zhenzhong Feng, Li Ma, Bo Zhu, Nan Yao, Danna Wang, Huiming Dong. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinomaWorld Journal of Surgical Oncology 2014; 12(1): 118 doi: 10.1186/1477-7819-12-118
10
Minsoo Kang, Suhyun Kim, Jesang Ko. Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancerThe FASEB Journal 2019; 33(3): 4248 doi: 10.1096/fj.201802018R
11
M. Cheng, L. Yang, R. Yang, X. Yang, J. Deng, B. Yu, D. Huang, S. Zhang, H. Wang, F. Qiu, Y. Zhou, J. Lu. A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expressionCarcinogenesis 2013; 34(10): 2292 doi: 10.1093/carcin/bgt181
12
Zhaoting Yang, Chengye Zhang, Wenbo Qi, Yan Cui, Yanhua Xuan. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinomaExperimental Cell Research 2018; 373(1-2): 145 doi: 10.1016/j.yexcr.2018.10.006
13
Shiwu Wu, Lan Yu, Danna Wang, Lei Zhou, Zenong Cheng, Damin Chai, Li Ma, Yisheng Tao. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicryBMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-535
14
Carole Mélin, Aurélie Perraud, Hussein Akil, Marie-Odile Jauberteau, Philippe Cardot, Muriel Mathonnet, Serge Battu. Cancer Stem Cell Sorting from Colorectal Cancer Cell Lines by Sedimentation Field Flow FractionationAnalytical Chemistry 2012; 84(3): 1549 doi: 10.1021/ac202797z
15
Chih-Sin Hsu, Chien-Yi Tung, Chih-Yung Yang, Chi-Hung Lin, Wael El-Rifai. Response to Stress in Early Tumor Colonization Modulates Switching of CD133-Positive and CD133-Negative Subpopulations in a Human Metastatic Colon Cancer Cell Line, SW620PLoS ONE 2013; 8(4): e61133 doi: 10.1371/journal.pone.0061133
16
Wei Rao, Shuting Zhao, Jianhua Yu, Xiongbin Lu, Debra L. Zynger, Xiaoming He. Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsulesBiomaterials 2014; 35(27): 7762 doi: 10.1016/j.biomaterials.2014.06.011
17
Wei-Chih Kuan, Daniel Horák, Zdeněk Plichta, Wen-Chien Lee. Immunocapture of CD133-positive cells from human cancer cell lines by using monodisperse magnetic poly(glycidyl methacrylate) microspheres containing amino groupsMaterials Science and Engineering: C 2014; 34: 193 doi: 10.1016/j.msec.2013.09.009
18
Alireza Mirzaei, Gholamreza Tavoosidana, Mohammad Hossein Modarressi, Afshin Abdi Rad, Mohammad Sadegh Fazeli, Reza Shirkoohi, Masoumeh Tavakoli-Yaraki, Zahra Madjd. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patientsTumor Biology 2015; 36(6): 4801 doi: 10.1007/s13277-015-3132-9
19
Galina Botchkina. Colon cancer stem cells – From basic to clinical applicationCancer Letters 2013; 338(1): 127 doi: 10.1016/j.canlet.2012.04.006
20
XUEFANG WU, FENG LUO, JINBANG LI, XUEYUN ZHONG, KUNPING LIU. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathwayInternational Journal of Oncology 2016; 48(4): 1333 doi: 10.3892/ijo.2016.3360
21
Shan-shan Zhang, Zhi-peng Han, Ying-ying Jing, Shuang-fen Tao, Tie-jun Li, Hao Wang, Yang Wang, Rong Li, Yang Yang, Xue Zhao, Xiao-dong Xu, En-da Yu, Yao-cheng Rui, Hou-jia Liu, Li Zhang, Li-xin Wei. CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patientsBMC Medicine 2012; 10(1) doi: 10.1186/1741-7015-10-85
22
Phaik-Leng Cheah, Jing Li, Lai-Meng Looi, Kean-Hooi Teoh, Diana Bee-Lan Ong, Mark J. Arends. DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinomaPeerJ 2018; 6: e5530 doi: 10.7717/peerj.5530